A Buchwald
Overview
Explore the profile of A Buchwald including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raddatz D, Nolte W, Rossbach C, Leonhardt U, Buchwald A, Scholz K, et al.
Exp Clin Endocrinol Diabetes
. 2008 Sep;
116(8):461-7.
PMID: 18770489
Background: Diabetes in liver cirrhosis is associated with a blunted insulin response, which might be explained by an impaired release of the incretin hormone glucagon-like peptide 1 (GLP-1) into the...
2.
Hausmann M, Dellweg S, Osborn C, Heinemann L, Buchwald A, Rosskamp R, et al.
Diabetes Obes Metab
. 2006 Aug;
8(5):574-80.
PMID: 16918593
Aim: This controlled proof-of-concept study investigated inhaled insulin (INH) as adjunctive therapy to existing oral antidiabetic agents in subjects with type 2 diabetes. Methods: Twenty-four subjects with type 2 diabetes...
3.
Raddatz D, Rossbach C, Buchwald A, Scholz K, Ramadori G, Nolte W
Exp Clin Endocrinol Diabetes
. 2005 Jun;
113(5):268-74.
PMID: 15926112
Background: Hyperglucagonemia has been described to be associated with insulin resistance in patients with liver cirrhosis. Portosystemic shunts may be involved in the etiology of hyperglucagonemia. To test this hypothesis...
4.
Evans D, Buchwald A, Beil F
J Mol Med (Berl)
. 2003 Aug;
81(10):645-54.
PMID: 12937897
The -1131T>C polymorphism in the newly identified apolipoprotein A5 (APOA5) gene has been associated with elevated plasma triglycerides. We determined its incidence in 915 patients attending a lipid outpatient clinic....
5.
Buchwald A, Derendorf H, Ji F, Nagaraja N, Wu W, Bodor N
Pharmazie
. 2002 Mar;
57(2):108-14.
PMID: 11878185
Cannabinoids are able to reduce elevated intraocular pressure; however, their use in glaucoma treatment is not approved due to severe systemic side effects. New cannabinoid derivatives have been designed based...
6.
van Toor B, Buchwald A, Stengele E, Trenk D, Gercek C, de Mey C
Int J Clin Pharmacol Ther
. 2001 May;
39(4):173-8.
PMID: 11332874
Aim: This study investigated the bioavailability of single doses of 1.12 and 2.24 mg chlorphenamine maleate applied intranasally (0.4% nasal spray) relative to a single peroral dose of 8 mg...
7.
Buchwald A, Browne C, Wu W, Ji F, Bodor N
Pharmazie
. 2000 Apr;
55(3):196-201.
PMID: 10756540
Cannabinoids have intraocular pressure (IOP) lowering effects, thus, they have a therapeutic potential in the treatment of glaucoma. Unfortunately, in the same time, they show CNS and cardiovascular effects as...
8.
Wulf G, Unterhalt M, Buchwald A, Zenker D, Kreuzer H, Hiddemann W
Acta Haematol
. 1999 Aug;
101(4):209-12.
PMID: 10436304
Dysfibrinogenemia accounts for approximately 0.7% of thrombophilia in patients with venous thromboembolic disease. In 20% of these patients, plasma thrombophilic dysfibrinogen is below 1.0 mg/ml, defining hypodysfibrinogenemia. We describe a...
9.
Buchwald A, Hochhaus G
Int J Clin Pharmacol Ther
. 1999 Jan;
36(12):652-60.
PMID: 9877002
Background: Salmeterol xinafoate is a highly selective beta2-adrenoceptor for the maintenance treatment of asthma in adults and children. Objective: To review the pharmacokinetics, clinical pharmacology, and therapeutic properties of a...
10.
Wieckhorst A, Buchwald A, Unterberg C
Am J Cardiol
. 1998 Apr;
81(7):933-5.
PMID: 9555788
The necessity of routine invasive implantable cardioverter-defibrillator (ICD) testing before hospital discharge was analyzed in 268 patients. In 98% of the patients, invasive ICD testing was not necessary if a...